Vicarious Surgical Inc.

NYSE:RBOT Stock Report

Market Cap: US$71.8m

Vicarious Surgical Management

Management criteria checks 3/4

Vicarious Surgical's CEO is Adam Sachs, appointed in Jan 2014, has a tenure of 10.92 years. total yearly compensation is $3.13M, comprised of 17.1% salary and 82.9% bonuses, including company stock and options. directly owns 6.75% of the company’s shares, worth $4.85M. The average tenure of the management team and the board of directors is 3.3 years and 3.3 years respectively.

Key information

Adam Sachs

Chief executive officer

US$3.1m

Total compensation

CEO salary percentage17.1%
CEO tenure10.9yrs
CEO ownership6.8%
Management average tenure3.3yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate

Nov 30
We're Keeping An Eye On Vicarious Surgical's (NYSE:RBOT) Cash Burn Rate

Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Aug 16
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Mar 05
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Nov 24
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

Aug 24

Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Jul 18
Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Vicarious Surgical: Cash Burn Adds To Downside Risk

May 26

Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02

Feb 13

Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03

Nov 07

Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02

Aug 08

Vectoring In On Vicarious Surgical Inc.

Jun 23

Vicarious Surgical: Developing Minimally Invasive VR Surgical System

Nov 29

CEO Compensation Analysis

How has Adam Sachs's remuneration changed compared to Vicarious Surgical's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$62m

Jun 30 2024n/an/a

-US$61m

Mar 31 2024n/an/a

-US$61m

Dec 31 2023US$3mUS$537k

-US$71m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$78m

Mar 31 2023n/an/a

-US$64m

Dec 31 2022US$5mUS$531k

US$5m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$18m

Mar 31 2022n/an/a

US$13m

Dec 31 2021US$6mUS$268k

-US$35m

Sep 30 2021n/an/a

-US$61m

Jun 30 2021n/an/a

-US$19m

Mar 31 2021n/an/a

-US$15m

Dec 31 2020US$187kUS$180k

-US$13m

Compensation vs Market: Adam's total compensation ($USD3.13M) is above average for companies of similar size in the US market ($USD653.16K).

Compensation vs Earnings: Adam's compensation has been consistent with company performance over the past year.


CEO

Adam Sachs (32 yo)

10.9yrs

Tenure

US$3,134,667

Compensation

Mr. Adam David Sachs is Co-Founder at Vicarious Surgical Inc. in 2014. He serves as Chief Executive Officer and Director of Vicarious Surgical Inc. (Formerly, D8 Holdings Corp.) since September 2021. He se...


Leadership Team

NamePositionTenureCompensationOwnership
Adam Sachs
Co-Founder10.9yrsUS$3.13m6.75%
$ 4.8m
Sammy Khalifa
Co-founder3.3yrsUS$1.82m2.85%
$ 2.0m
William Kelly
CFO & Treasurer3.3yrsUS$1.64m0.028%
$ 20.4k
Randolph A. Clark
Presidentless than a yearno datano data
Barry Greene
Co-founder & Chief Medical Officerno datano data2.2%
$ 1.6m
John Mazzola
Chief Operating Officer2.9yrsno data0.053%
$ 37.8k
Erin Checka
Head of Legal & Secretaryno datano datano data
Emma Plouffe
Vice President of Business Operations & People3.3yrsno datano data

3.3yrs

Average Tenure

49yo

Average Age

Experienced Management: RBOT's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Adam Sachs
Co-Founder3.3yrsUS$3.13m6.75%
$ 4.8m
Sammy Khalifa
Co-founder3.3yrsUS$1.82m2.85%
$ 2.0m
Beverly Huss
Independent Director2.2yrsUS$196.56k0.078%
$ 55.7k
Ric Fulop
Independent Director3.3yrsUS$195.77k0.063%
$ 45.4k
David D. Ho
Independent Director3.3yrsUS$198.45k0.15%
$ 108.8k
Victoria Carr-Brendel
Independent Director1.9yrsUS$447.60k0.054%
$ 38.6k
Donald F. Tang
Independent Director3.3yrsUS$185.14k0.71%
$ 508.4k

3.3yrs

Average Tenure

49yo

Average Age

Experienced Board: RBOT's board of directors are considered experienced (3.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:32
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vicarious Surgical Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Michael GormanBTIG
Matthew MiksicCredit Suisse
Adam MaederPiper Sandler Companies